Wells Fargo & Company »

Galmed Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Galmed Pharmaceuticals (GLMD) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Galmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Galmed Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galmed Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $11 9 1.33
2025-06-30 $17 9 1.89
2025-03-31 $12 9 1.44
2024-12-31 $57 18 3.17
2024-09-30 $122 18 6.83

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Galmed Pharmaceuticals

Citadel Advisors
Morgan Stanley
Two Sigma Investments
UBS Group
Sontag Advisory
TSFG
SBI Securities
Federation des caisses Desjardins du Quebec
Wells Fargo & Company
Advisor Group Holdings
Hanson McClain Advisors
TD Waterhouse Canada
Dogwood Wealth Management
Zrc Wealth Management

View all funds holding Galmed Pharmaceuticals